author-photo

Adnan Khattak

University of Western Australia

4

Papers

177

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

Association Between Immune-Related Adverse Events and Recurrence-Free Survival Among Patients With Stage III Melanoma Randomized to Receive Pembrolizumab or Placebo: A Secondary Analysis of a Randomized Clinical Trial

2020 JAMA Oncology
Show All
- Source
- Cite
- Save
Citations (125)
Prognostic and predictive value of AJCC-8 staging in the phase III EORTC1325/KEYNOTE-054 trial of pembrolizumab vs placebo in resected high-risk stage III melanoma

2019 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (46)
Abstract CT001: Pembrolizumab versus placebo after complete resection of high-risk stage III melanoma: Efficacy and safety results from the EORTC 1325-MG/Keynote 054 double-blinded phase III trial

2018 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)